Synthesis of modified 1,3,4-thiadiazole incorporating substituted thiosemicarbazide derivatives: Elucidating the in vitro and in silico studies to develop promising anti-diabetic agent

Hybrid molecules based on the 1,3,4-thiadiazole were always the choice of different researchers due to their significant application in medicinal as well as pharmaceutical application. In the present study, twenty analogs of 1,3,4-thiadiazole-bearing thiosemicarbazide moiety (1-20) were synthesized and screened for their anti-diabetic profile. The synthesized compounds were spectroscopically characterized through different spectroscopic techniques such as 1HNMR, 13CNMR, and HREI-MS. Comparing the whole set of afforded compounds to the standard glimepiride drugs (16.01 +/- 0.02 mu M), the inhibition profiles against alpha-amylase ranged from 21.02 +/- 0.08 to 54.08 +/- 0.04 mu M. Comparing synthetic analogs to normal glimepiride (IC50 = 14.06 +/- 0.05 mu M), the range of alpha-glucosidase activity was likewise variable, ranging from 18.04 +/- 0.07 mu M to IC50 = 51.05 +/- 0.03 mu M (against alpha-glucosidase). Compound 19 demonstrated high potency among the produced analogs since it had both ortho- nitro substitution at the aryl ring. The pattern of substitutions around the aryl ring was used for all analogs to determine the structure-activity relationship. In addition, a molecular docking study was conducted on the potent analogs to examine the interactions between the active residues of the targeted enzymes with the synthesized compound. The synthesized molecule showed different types of interactions with amino acid. The outcome demonstrates that these compounds provide several essential interactions with the active sites of enzymes, hence strengthening their enzymatic activity for the future prediction as drug competitors.